Physician

Michael Yoslov, D.O., FACOI

According to 2025 Medicare claims, Michael Yoslov, D.O., FACOI (NPI: 1780653956) practices nephrology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is NORTHEAST KIDNEY CARE LLC (NPI: 1023889565; TIN: 933742471) and primary practice location at 08360-7059.

Yoslov's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 612 traditional Medicare patients, billed 2,468 HCPCS/CPT codes, and received $182,169 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,841 prescription claims across 305 beneficiaries totaling $972,691 in drug costs, led by Kerendia (Finerenone). Open Payments data shows 101 records totaling $18,319. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $10,573 and ending at $182,169. Concurrently, Part D prescription costs have risen steadily, from $30,154 to $972,691. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	49	111	$10,573
2017	458	1,775	$227,417
2018	547	1,852	$184,526
2019	727	2,357	$213,139
2020	661	2,122	$203,682
2021	638	2,379	$258,542
2022	545	1,923	$210,659
2023	623	2,061	$195,615
2024	612	2,468	$182,169

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	97	300	$30,154
2016	23	103	$16,285
2017	71	460	$58,731
2018	103	615	$45,223
2019	148	749	$143,938
2020	165	948	$334,050
2021	194	1,028	$223,799
2022	230	1,386	$317,350
2023	300	1,804	$715,936
2024	305	1,841	$972,691

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	146	185	$135
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	129	236	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	200	376	$81
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	267	824	$64
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	241	506	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kerendia	Finerenone	333	17,460	$360,954
Farxiga	Dapagliflozin Propanediol	115	7,170	$126,542
Rayaldee	Calcifediol	63	2,310	$102,709
Lokelma	Sodium Zirconium Cyclosilicate	24	1,344	$19,240
Veltassa	Patiromer Calcium Sorbitex	24	1,044	$16,896

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	101	$18,319	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Yoslov, D.O., FACOI?

Tedicare shows public-source Medicare data for Michael Yoslov, D.O., FACOI (NPI 1780653956), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Yoslov, D.O., FACOI have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Yoslov, D.O., FACOI?

Michael Yoslov, D.O., FACOI is linked to NORTHEAST KIDNEY CARE LLC (billing NPI 1023889565) in the available physician profile data.

Does Michael Yoslov, D.O., FACOI have Open Payments data?

Michael Yoslov, D.O., FACOI has 101 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.